FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears Auto-Contouring Software

FDA clears a Mim Software 510(k) for its deep learning auto-contouring software, Contour ProtgAI.

Medical Devices

Draft Guide on Peripheral Vascular Atherectomy Devices

FDA makes available a draft guidance entitled Select Updates for Peripheral Vascular Atherectomy Devices -Premarket Notification [510(k)] Submissions....

Federal Register

Consumer Organizations Sought for Advisory Panel Selections

Federal Register notice: FDA seeks consumer organizations interested in participating in selecting voting or nonvoting consumer representatives to ser...

Federal Register

Info Collection on Social Behavioral Sciences Data

Federal Register notice: FDA seeks comments on a new information collection for data to support cross-center collaboration for social behavioral scien...

Federal Register

New Study on Disclosures in Drug Ads

Federal Register notice: FDA seeks comments on a new information collection entitled Examination of Secondary Claim Disclosures and Biosimilar Disclos...

Medical Devices

Comments on AI in Radiological Imaging

Two stakeholders comment to FDA on the agencys public workshop on the evolution of artificial intelligence in radiological imaging.

WLF Wants Access to PGx Information

Washington Legal Foundation supports a petition seeking to block FDA from suppressing the dissemination of pharmacogenomics data.

Human Drugs

Identify Barriers to Enrolling Trial Subgroups: PhRMA

PhRMA says the FDA Office of Minority Health and Health Equity should work with industry to identify and publicize best practices in building subgroup...

Federal Register

Panel to Discuss Mallinckrodts NDA for Terlipressin

Federal Register notice: FDA announces a 7/15 Cardiovascular and Renal Drugs Advisory Committee online meeting to review a Mallinckrodt NDA for terlip...

Federal Register

Stakeholder Participation for Drug User Fee Reauthorization

Federal Register notice: FDA seeks patient and consumer advocacy groups, healthcare professionals, and scientific and academic experts to participate ...